Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 225 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTXW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.14 | 15:08:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1397 | 0.1397 | 0.14 | 0.14 | 0.14 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 3 | 225 | 0.1396999 | 31 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 100 | 0.14 | USD |
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.56M | 18.28M | - | 0 | -4.79M | -0.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News BriaCell Therapeutics
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BCTXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC). MBC is breast cancer that has spread to other tissues. Bria-IMT(TM) is a targeted cell-based immunotherapy. Additionally, BriaCell is developing, Bria-OTS(TM), a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical study initially targeting breast cancer, with extension to prostate cancer, and other cancers. |
NASDAQ:BCTXW -
What is the current BriaCell Therapeutics Corporation share price?
The current share price of BriaCell Therapeutics Corporation is US$ 0.14
How many BriaCell Therapeutics Corporation shares are in issue?
BriaCell Therapeutics Corporation has 18,284,000 shares in issue
What is the market cap of BriaCell Therapeutics Corporation?
The market capitalisation of BriaCell Therapeutics Corporation is USD 2.56M
What is the 1 year trading range for BriaCell Therapeutics Corporation share price?
BriaCell Therapeutics Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of BriaCell Therapeutics Corporation?
The price to earnings ratio of BriaCell Therapeutics Corporation is -40.44
What is the reporting currency for BriaCell Therapeutics Corporation?
BriaCell Therapeutics Corporation reports financial results in USD
What is the latest annual profit for BriaCell Therapeutics Corporation?
The latest annual profit of BriaCell Therapeutics Corporation is USD -4.79M
What is the registered address of BriaCell Therapeutics Corporation?
The registered address for BriaCell Therapeutics Corporation is SUITE 300 - 235 WEST 15TH STREET, VANCOUVER, BRITISH COLUMBIA, V7T 2X1
What is the BriaCell Therapeutics Corporation website address?
The website address for BriaCell Therapeutics Corporation is www.briacell.com
Which industry sector does BriaCell Therapeutics Corporation operate in?
BriaCell Therapeutics Corporation operates in the BUSINESS SERVICES, NEC sector
